Physician profile
Steven E Gelb
NPI 1437596830
$91,538.70
in general payments reported to CMS, 2019-2025
9 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $884 · 2020: $5,839 · 2021: $9,982 · 2022: $49K · 2023: $25K · 2024: $651 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $20K · Food and Beverage: $3,356 · Travel and Lodging: $2,694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $20,000.00 |
| Food and Beverage | $3,355.83 |
| Travel and Lodging | $2,693.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $80,119.58 | 2019-2023 | Da Vinci Surgical System |
| Tela Bio, INC. | $8,771.63 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Medtronic, INC. | $1,153.02 | 2021-2022 | |
| Abbvie INC. | $555.61 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $547.48 | 2021-2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Myriad Genetic Laboratories, INC. | $238.61 | 2021-2022 | |
| Acelrx Pharmaceuticals, INC. | $71.45 | 2020 | |
| Solta Medical, A Division of Bausch Health US, LLC | $65.54 | 2024 | |
| Redhill Biopharma INC. | $15.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Gelb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.